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NUMEROUS investigations have dealt
with the possibility that immunity against
virus-induced neoplasia may be protective
against subsequent exposure to chemical
carcinogens. Despite some early evidence
in support ofthis (Price et al., 1]977; Whit-
mire & Huebner, 1972) more recent ex-
perimentation has indicated that no simple
correlation exists between prior exposure
to oncogenic viruses and/or viral antigens
and susceptibility to chemically induced
cancer (Basombrio et al., 1977; Mishra
et al., 1977). On the other hand, several
laboratories have reported that treatment
of normal cells or hosts with chemical
carcinogens can lead to the expression of
either endogenous virus particles or endo-
genous C-type viral RNA (Weiss et al.,
1971; Young et al., 1978). This suggests the
possibility that endogenous virus expres-
sion may occur in vivo after injection of
carcinogens. Such a situation could in turn
induce auto-immunization, with potential
protection against exogenous oncogenic
virus.
We decided to pursue this possibility
using the retrovirus-induced avian sar-
coma. The sarcoma-bearing chicken has a
number of advantages for the study of
cancer development: 1. The tumour host
is usually an outbred, non-laboratory-
adapted animal (Vogt, 1965) though in-
bred strains and pathogen-free strains are
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also available for certain types of study;
2. The virus which induces malignant
transformation is one of a family of agents
which are oncogenic in nature as well as
in the laboratory (Bauer, 1974); 3. The
chicken lends itself to the separation of
lymphoid cell populations of diverse
origin, and thereby to a differential defini-
tion of immunological capacity (Cooper
et al., 1965); 4. Considerable work has been
done on the development of humoral and
cellular immunity in this system, and it is
known that both viral and non-viral
antigens play roles in the induction of
tumour-associated immunity (Kurth,
1976); 5. Progressive tumour growth is
usually the result ofrecruitment ofnewly-
transformed cells into the tumour mass,
rather than mitosis of previously infected
cells, underscoring the requirement for
continued production of progeny-trans-
forming virus (Ponten, 1964); 6. Avian
sarcomas frequently undergo spontaneous
regression (the percentage varies with the
source of virus, the dose and route of the
viral inoculum, and the genotype of the
chicken), making them useful for the study
of tumour enhancement (Kurth, 1976).
The purpose of this paper is to point
out the differential effects of chemical
carcinogens on subsequent virus-induced
tumour development in different hosts.
The Prague strain, subgroup A (PrA),
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of avian sarcoma virus (ASV), kindly pro-
vided by Dr P. Vogt, University of
Southern California, was used in these
experiments. Viruses were propagated in
cultures of CEF cells according to a pre-
viously published procedure (Temin &
Rubin, 1958). Supernatant fluids usually
containing about 105 focus-forming units
(FFu)/ml were collected after 24 h from
cultures of almost completely transformed
cells, clarified by low-speed centrifugation
and frozen at - 70°C until use. Both male
and female chickens, 70-74 days old,
were injected in the right wing webs with
transformed culture supernatant fluid
containing - 103 FFu of virus.
3-Methylcholanthrene (MCA) and 7,12-
dimethylbenzanthracene (DMBA) were
obtained from Sigma Chemical Co., St
Louis, Mo. Chickens were injected i.m.
into the right thigh with either 5 mg
DMBA in 0 1 ml dimethylsulphoxide
(DMSO) or 2 mg MCA in 0-1 ml DMSO at
7,14 and 21 days of age. Control animals
received 0-1 ml of DMSO without car-
cinogen into the right thigh. In addition,
all animals were injected with 01 ml
DMSO into the left thigh. Tumour de-
velopment, when it occurred, was local
in each instance, i.e. in the thigh or wing
web challenged with carcinogen or virus
respectively.
Animals were of either of two flocks.
Leucosis-free eggs and chickens were
purchased from the breeding colonies
of Institut Armand Frappier, Laval,
Quebec, and are designated IAF. Non-
pathogen-free chickens were obtained
from the nearby Couvoir de Laval, Laval,
Quebec and are designated CL. Animals of
these two flocks were negative and posi-
tive, respectively, for expression of avian
retrovirus-associated group-specific (GS)
antigens (Sarma et al., 1964). Virus propa-
gation, for the purpose of preparing viral
stocks, was carried out exclusively with
chicken embryo fibroblast (CEF) cells
derived from the GS-eggs referred to
above. CEF cells from each of the two
sources were susceptible to transformation
and permissive for virus growth for viruses
of each of subgroups A, C and D.
Both MCA and DMBA have been shown
by other investigators to be carcinogenic
in fowls (Peacock & Peacock, 1956;
Lerman et al., 1976). We observed each of
these agents, when dissolved in DMSO, to
have strikingly different oncogenic poten-
tial in chickens, depending on their
source. Table I summarizes the data oftwo
separate experiments whichyielded similar
results, and in which tumour incidence in
each of IAF and CL chickens, following
inoculation with MCA or DMBA and/or
avian sarcoma virus (ASV), was observed.
MCA was found to induce moderate
tumour nodules in 7/11 IAF animals,
but was non-oncogenic for 11 CL birds.
In contrast, DMBA injection gave rise to
small tumour nodules in only 3/12 IAF
chickens, while larger primary tumours
developed in 10/12 CL animals.
TABLE I.-Effect of prior inoculation with chemical carcinogens on development of avian
sarcoma virus-induced (ASV) tumour growth
Tumour
incidence
after
Tumour
incidence
after
No. of
animals with
progressively
Source of carcinogen challenge growing
chickens* Carcinogenit inoculation with ASV tumours
IAF AICA 7/11 10/10 0/10
IAF DAIBA 3/12 12/12 10/12
IAF none none 12/12 0/12
CL lICA 0/11 5/11 5/11
CL DMBA 10/12 4/12 0/12
CL none none 0/12 0/12
* Institut Armand Frappier (IAF), Laval, Quebec, or the Couvoir de Laval (CL), Laval, Quebec, as
explained in the text.
t 3-methyleholanthrene (1INCA) or 7,12-dimethylbenzanthracene (DMBA). Animals not injected with
carcinogen received dimethylsullphoxide (DMISO) and served as controls.
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These tumours generally first became
palpable at - 22-28 days of age, or within
1 week ofthe final injection of carcinogen.
Preliminary experiments had shown that
multiple doses of drug were required to
induce tumour development. These pri-
mary tumours grew to various dimensions,
but in all cases regressed. Regression began
in about the 5th week after the onset of
tumour growth, and was complete in all
cases 2 weeks later. In no instance did
nodules appear at sites which had been
injected with DMSO alone.
After theinoculation ofboth carcinogen-
injected and control chickens with ASV,
dramatically different patterns of tumour
growth emerged. These results are sum-
marized in Table I. Tumour growth was
usually evident by about 7 days after
viral challenge and was measured across
two perpendicular diameters by means of
a pair of calipers, at least twice weekly.
IAF chickens were 100% susceptible to
avian sarcoma development. When non-
carcinogen-injected, normal IAF animals
were inoculated with ASV, however,
tumours grew progressively for about 2
weeks and then regressed. A similar profile
of tumour development followed by re-
gression was seen with 10/10 IAF chickens
previously inoculated with MCA. In IAF
animals that had been injected with
DMBA, however, there was a different
result. The ASV-induced tumours in these
animals continued to grow progressively
to kill their hosts about 1 month after viral
inoculation.
In contrast, 12/12 non-chemically
treated CL chickens were totally resistant
to virus-induced neoplasia. When CL
animals were first exposed to chemical
carcinogens, however, there wasadramatic
stimulation of virus-induced tumour
growth. This was manifested by the
appearance of tumours in 5/11 chickens
previously exposed to MCA and in 4/12
that received DMBA. In the case of the
DMBA-injected animals, these tumours
ultimately regressed in a way similar to
the IAF controls. Tumour development in
the 5 CL birds that had been previously
exposed to MCA was progressive, how-
ever, and resulted in death about 1 month
after virus inoculation.
The stimulation ofASV-induced tumour
growth following exposure to chemical
carcinogens led us to question whether
this might be due to immunosuppression.
We have previously shown that the pre-
sence of specific lymphocyte stimulation
in response to extracts or supernatant
fluids of transformed CEF cells can be
used to monitor tumour immunity in
chickens bearing avian retrovirus-induced
neoplasms (Israel & Wainberg, 1977).
Accordingly, we tested the peripheral
blood lymphocytes of animals from each
of the above experimental groups, as well
as healthy controls, for ability to undergo
proliferative response to relevant antigens.
Blood was obtained 2-3-5 weeks after
inoculation with oncogenic virus or saline,
and the mononuclear fraction, almost
entirely lymphocytes, was purified by
Ficoll-Isopaque gradient centrifugation
(Boyum, 1968). The cells were resuspended
in bicarbonate-buffered RPMI medium,
as described by Israel & Wainberg (1977)
to a final concentration of 106/ml. Cul-
tures containing 1 ml of this suspension
were incubated in the presence or absence
of various test antigens for 27 h at 370C.
Each assay was carried out with at least
4 replicate samples. 3H-thymidine (1 HtCi/
tube; New England Nuclear Corp., Boston,
Mass.) was added to the culture tubes for
the final 16 h of incubation, after which
the samples were processed by trichloro-
acetic acid precipitation on to filter pads
and the amount of incorporated radio-
activity was determined. Lymphocyte
stimulation indices were calculated as the
ratio between amount of radioactivity
incorporated in the presence and absence
of antigenic stimulus.
The results of two typical experiments
are presented in Table JI, and indicate
some degree of specific immunity in vir-
tually all virus-injected animals tested.
No differences were found, however, be-
tween levels of response in animals that
had or had not been pretreated with
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TABLE II.-Stimulation ofperipheral lymphocytes ofnormal and tumour-bearing chickens
Source of
Expt chickens
I IAF
CL
IAF
CL
IAF
CL
2 IAF
IAF
IAF
IAF
IAF
Carcinogen
MCA
MCA
DMBA
DMBA
Later
inoculation
with ASV
+
Stimulation indices with culture fluids from:
ASV-
trans-
formed
N-CEF* Pt CEF P
1-05 NSt 2-49 < 0-01
1-17 NS 3-62 < 0-01
0-88 NS 1-73 < 0 05
1-36 < 0 05 2-30 < 0-01
0-82 NS 1-22 NS
1-31 NS 1-45 < 0.05
0 93 NS 1-92 < 0.01
1-14 NS 2-58 < 0-01
1-25 NS 3-11 <0-01
1-07 NS 1-19 NS
0 78 NS 1-36 NS
* CEF, chicken embryo fibroblasts.
t Probability of difference from unstimulated control cultures (Student's t test).
t NS, not significant.
TABLE III.-Cumulative effects on cellular
immunity against avian sarcomasfollow-
ing inoculation of chickens with both
chemical carcinogens and oncogenic virus
Animals showing
significant immunity*/
number tested, when
antigenic stimuli
were culture fluids
from:
Source
of
chickens
IAF
IAF
IAF
IAF
CL
CL
CL
CL
Carcino-
gen
MCA
DMBA
MCA
DMBA
Inocu-
lation
with
ASV
+
+
+
+
N-CEF
1/10
1/12
1/12
0/6
3/11
3/12
1/12
0/6
trans-
formed
CEF
8/10
9/12
11/12
0/6
9/11
10/12
10/12
2/6
* Animals whose lymphocytes incorporated sig-
nificantly more [3H]-TdR than corresponding un-
stimulated cultures (Student's t test.)
chemical carcinogens. This was found to
be true in each of 8 separate experiments,
the cumulative results of which are
presented in Table III.
In addition, we monitored humoral
immune response in these hosts by means
of an indirect immunofluorescence assay
(Wainberg et al., 1977) using chicken sera
and a rabbit anti-chicken IgG fluorescein-
isothiocyanate conjugated serum (Miles
Biochemicals, Elkhart, Indiana). Prepara-
tions of normal and ASV-transformed
CEF cells were observed for fluorescence
in a Zeiss photomicroscope equipped with
both phase-contrast and transmission UV
optics. The percentages offluorescent cells
in the preparations were determined by
counting at least 5 fields with at least 500
cells in each.
Sera were obtained at times ranging
from 2 to 3-5 weeks after inoculation with
ASV or, in the controls, saline. The results
are presented in Table IV, and indicate
TABLE IV.-Immunofluorescence staining
capacity ofserafrom normal and tumour-
bearing chickens against ASV-trans-
formed CEF cells
Source
of
chickens
IAF
IAF
IAF
IAF
IAF
IAF
CL
CL
CL
CL
CL
CL
Carcino-
gen
MCA
MCA
DMBA
DMBA
MCA
MCA
DMBA
DMBA
Inocu-
lation
with
ASV
+
+
% cells stained when
targets were:
ASV-
trans-
formed
N-CEF CEF
4-2 41-4
3-7 5-3
5-3 33-1
4-0 6-2
3-6 27-2
2-1 2-4
6-8 32-5
6-4 3-9
7-3 36-0
5-6 7-7
3-4 29-6
5-2 5-7
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that immune sera derived from ASV-
injected hosts stained 30-40% of PrA-
transformed CEF cells. This was true
whether or not such animals had received
prior inoculations of chemical carcinogens.
Immune chicken sera stained only mini-
mal numbers of normal CEF cells
( 4-5%) whilst similarly low levels of
reactivity were recorded with normal
chicken sera (NCS) tested against either
normal or transformed CEF cells. Sera
from animals (- 50 days old) that had
been injected with chemical carcinogens
but not oncogenic virus behaved similarly
to normal sera.
Thus, the data of these experiments
indicate that inoculation into chickens of
the chemical carcinogens MCA or DMBA,
at times before the injection of ASV, can
have a differential stimulatory effect on
oncogenic virus-induced tumour growth.
Such a result is apparently dependent on
both the source of the chickens and the
type of chemical carcinogen. For example,
prior exposure to DMBA, but not to MCA,
enhanced ASV-induced tumour growth
in IAF birds. In contrast, exposure to
either carcinogen proved stimulatory to
ASV-induced neoplasia in CL animals,
which were otherwise totally resistant to
ASV-induced tumour growth. Oddly, the
CL and IAF chickens used were preferen-
tially susceptible to the tumour-promoting
effects of DMBA and MCA, respectively.
These data indicate that no simple rela-
tionship exists between prior inoculation
with carcinogen and subsequent suscepti-
bility to virus-induced neoplasia. Rather,
whilst stimulation of tumour growth can
clearly be demonstrated in many situa-
tions, such an outcome is probably gover-
ned by a wide range, of genetic, environ-
mental and other factors. Thus, the
differences between groups of animals in
these experiments may be attributable to
group-specific (GS) antigen-expression
status, genotype, or virological, environ-
mental or other factors.
It has been shown (Medina et al., 1974)
that, although chemical carcinogens can
cause depressed levels of humoral and
cell-mediated immunity in mice, such
immunosuppression bears little relevance
to the carcinogenic potential of these
chemicals. This conclusion is comple-
mented by our own findings, which show
that enhanced growth of virus-induced
tumours, after exposure to chemical car-
cinogens, occurs in the absence of any
suppression of measurable anti-avian-
sarcoma immunity. Such a result was
obtained using both a cell-mediated and a
humoral assay for the detection ofrelevant
antitumour response.
We recognize that the considerations
discussed here are not all-inclusive with
respect to understanding the influence
of carcinogens on ASV-induced tumour
growth. We hope now to repeat certain of
our experiments using chickens of more
similar genetic background, and ifpossible
differing only at the locus controlling GS-
antigen activity, as a means of resolving
this problem more fully.
We wish to thank Ms Hoda Karam for the pre-
paration of the manuscript.
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